Elisabeth Fowler delivered the attached presentation at the Drug Information Association conference in Ottawa, Canada in November, 2009.

 

Read more 
 

World Health Advocacy co-hosted the "Access to Rx Drugs:  What Every Patient Should Know" workshop held in Toronto, ON on September 21 & 22, 2009.  Elisabeth Fowler helped to moderate the workshop and also delivered the attached presentation, providing an overview of public engagement in HTA evaluations in other countries.

Read more 
 
How are new drugs developed?
Written by Elisabeth Fowler,

World Health Advocacy co-hosted the "Access to Rx Drugs:  What Every Patient Should Know" workshop held in Toronto, ON on September 21 & 22, 2009.  Elisabeth Fowler helped to moderate the workshop and also delivered the attached presentation, providing an overview of the process of medical innovation.

Read more 
 
Information and patients
Written by Elisabeth Fowler,

Presentation in Tokyo, Japan at the by Elisabeth Fowler as part of a panel on chronic disease and the impact of early intervention.  The audience of the "Impacts and implications of chronic diseases" meeting consisted of approximately 50 patient representatives from various groups across Japan.

Read more 
 
Engaging Patients in HTA in Canada
Written by Elisabeth Fowler,

Presentation at the Canadian Agency for Drugs and Technologies in Health 2009 Symposium

Engaging Patients in HTA in Canada:  what's working and what needs to be done?

By:  Elisabeth Fowler, World Health Advocacy & Durhane Wong-Rieger, Institute for Optomizing Health Outcomes

Read more 
 
<< Start < Prev 1 2 Next > End >>

Page 1 of 2